Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00030186
Status:
COMPLETED
Last Update Posted:
2012-08-23
First Post:
2002-02-07
Brief Title:
Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-01
Start Date Type:
None
Primary Completion Date:
2003-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-02
Completion Date Type:
ACTUAL
First Submit Date:
2002-02-07
First Submit QC Date:
February 7 2002
Study First Post Date:
2002-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2012-05-03
Disp First Submit QC Date:
May 3 2012
Disp First Post Date:
2012-05-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2012-08-14
Last Update Post Date:
2012-08-23
Last Update Post Date Type:
ESTIMATED